Cardinal Health CFO Sells $8,233,444 in Stock (CAH)
Cardinal Health (NYSE:CAH) CFO Jeffrey William Henderson sold 118,093 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $69.72, for a total transaction of $8,233,443.96. Following the sale, the chief financial officer now directly owns 73,004 shares of the company’s stock, valued at approximately $5,089,839. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of Cardinal Health (NYSE:CAH) traded up 0.42% during mid-day trading on Monday, hitting $71.24. 1,526,235 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $74.40. The stock has a 50-day moving average of $70.6 and a 200-day moving average of $69.35. The company has a market cap of $24.150 billion and a price-to-earnings ratio of 20.99.
Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.25 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.3425 per share. This represents a $1.37 annualized dividend and a dividend yield of 1.93%. The ex-dividend date is Monday, September 29th.
A number of research firms have recently commented on CAH. Analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Separately, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $74.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Cardinal Health has a consensus rating of “Buy” and a consensus target price of $78.03.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Receive News & Ratings for Cardinal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.